Tower Research Capital (TRC)’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,050
| Closed | -$9.2K | – | 6312 |
|
|
2023
Q4 | $9.2K | Buy |
+2,050
| New | +$7.19K | ﹤0.01% | 4423 |
|
|
2023
Q3 | – | Sell |
-686
| Closed | -$8.41K | – | 6366 |
|
|
2023
Q2 | $8.41K | Buy |
686
+347
| +102% | +$4.43K | ﹤0.01% | 4436 |
|
|
2023
Q1 | $5K | Buy |
339
+149
| +78% | +$2.8K | ﹤0.01% | 5022 |
|
|
2022
Q4 | $3K | Buy |
190
+72
| +61% | +$2.07K | ﹤0.01% | 5283 |
|
|
2022
Q3 | $5K | Buy |
+118
| New | +$6.78K | ﹤0.01% | 5193 |
|
|
2022
Q2 | – | Sell |
-217
| Closed | -$10K | – | 6724 |
|
|
2022
Q1 | $10K | Buy |
217
+24
| +12% | +$1.44K | ﹤0.01% | 4387 |
|
|
2021
Q4 | $14K | Buy |
193
+30
| +18% | +$3.23K | ﹤0.01% | 4129 |
|
|
2021
Q3 | $24K | Buy |
163
+151
| +1,258% | +$45.8K | ﹤0.01% | 3575 |
|
|
2021
Q2 | $7K | Buy |
12
+3
| +33% | +$1.96K | ﹤0.01% | 4583 |
|
|
2021
Q1 | $6K | Buy |
9
+8
| +800% | +$5.75K | ﹤0.01% | 4622 |
|
|
2020
Q4 | $0 | Sell |
1
-7
| -88% | -$4.89K | ﹤0.01% | 5478 |
|
|
2020
Q3 | $6K | Buy |
+8
| New | +$6.84K | ﹤0.01% | 4322 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4630 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4461 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | -$1K | – | 4532 |
|
|
2016
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 3407 |
|
|
2016
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 4248 |
|
|
2016
Q1 | $1K | Buy |
+1
| New | +$984 | ﹤0.01% | 3836 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5194 |
|
|
2015
Q3 | – | Hold |
0
| – | -$1K | – | 4967 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4115 |
|
|
2015
Q1 | – | Sell |
-2
| Closed | -$7.22K | – | 5059 |
|
|
2014
Q4 | $8K | Buy |
+2
| New | +$11.6K | ﹤0.01% | 2368 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 3646 |
|
Tower Research Capital (TRC)'s MDVL Position: Q1 2024 in Review
Tower Research Capital (TRC) sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 2,050 shares — an estimated $9.2K sold.
Tower Research Capital (TRC) first reported a position in MDVL in Q4 2014 and held it in 16 quarters. The position peaked at $24K in Q3 2021. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.
- Tower Research Capital (TRC) reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,050 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $9.2K.
- Tower Research Capital (TRC) first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2014 and held it in 16 quarters.
- Tower Research Capital (TRC)'s MedAvail Holdings, Inc. Common Stock position peaked at $24K in Q3 2021.
- 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.